COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network

Patients with multiple myeloma frequently present with substantial immune impairment and an increased risk for infections and infection-related mortality. The risk for infection with SARS-CoV-2 virus and resulting mortality is also increased, emphasising the importance of protecting patients by vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ludwig, Heinz, Sonneveld, Pieter, Facon, Thierry, San-Miguel, Jesus, Avet-Loiseau, Hervé, Mohty, Mohamad, Mateos, Maria-Victoria, Moreau, Philippe, Cavo, Michele, Pawlyn, Charlotte, Zweegman, Sonja, Engelhardt, Monika, Driessen, Christoph, Cook, Gordon, Dimopoulos, Melitios A, Gay, Francesca, Einsele, Hermann, Delforge, Michel, Caers, Jo, Weisel, Katja, Jackson, Graham, Garderet, Laurent, van de Donk, Niels, Leleu, Xavier, Goldschmidt, Hartmut, Beksac, Meral, Nijhof, Inger, Schreder, Martin, Abildgaard, Niels, Hajek, Roman, Zojer, Niklas, Kastritis, Efstathios, Broijl, Annemiek, Schjesvold, Fredrik, Boccadoro, Mario, Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553271/
https://www.ncbi.nlm.nih.gov/pubmed/34756169
http://dx.doi.org/10.1016/S2352-3026(21)00278-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553271/
https://www.ncbi.nlm.nih.gov/pubmed/34756169
http://dx.doi.org/10.1016/S2352-3026(21)00278-7

Ejemplares similares